Acadia Pharmaceuticals | ACAD - Ebit





Ebit تغيير تاريخ
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Cara Therapeutics USD -5.94M 3.55M 2025-09
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Incyte USD 344.17M 39.71M 2026-03
J&J USD 6.62B 1.51B 2026-03
Moderna USD -1.39B 531M 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Pfizer USD 4.99B 340M 2026-03
Prothena USD 25.79M 53M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03